Cookie Consent by Privacy Policies website
Back to Elevai Labs

Investors

We rely on the capital markets for the growth of our brands.

View Stock Data

Latest Press Releases

View All
January 2, 2025

PMGC Holdings Inc. Following Skincare Subsidiary Sale, Embarks on Bold Growth Strategy

January 2, 2025

Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care Products

December 20, 2024

Elevai Labs Inc. Announces Name Change to PMGC Holdings Inc. and Redomicile to Nevada

Track all markets on TradingView
Elevai Labs Inc. (NASDAQ: ELAB) specializes in medical aesthetics and biopharmaceutical drug development, focusing on aesthetic innovations for skin, and treatments tied to obesity and metabolic health. Driven by a commitment to scientific research, we aim to transform personal health and beauty.
Pages
IR HomePress ReleasesFAQManagementStock DataContact
SEC FilingsGovernance
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Download Presentation
Copyright ©ElevaiLabs.
Privacy policyTerms and Conditions